# Rezolute, Inc.: filings

RZLT · Nasdaq · CIK 1509261 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/rzlt.md) · [Financials](/companies/rzlt/financials.md) · [Filings](/companies/rzlt/filings.md) · [Insiders](/companies/rzlt/insiders.md)

## Reports and events: 296 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 182, 4 173, 10-Q 45, 3 31, 424B3 31, EFFECT 29, CORRESP 25, UPLOAD 25, 10-K 16, POS AM 14, D 12, S-1/A 12, SC 13D 12, SC 13G/A 12, 424B5 11, DEF 14A 10, S-1 9, SC 13G 9, SCHEDULE 13G 8, SCHEDULE 13G/A 8, PRE 14A 7, S-3 7, D/A 4, NT 10-K 4, S-3/A 4, S-8 4, SC 13D/A 4, 10-K/A 3, 4/A 3, CT ORDER 3, PRER14A 3, 8-K/A 2, DEF 14C 2, DEFA14A 2, PRE 14C 2, PRER14C 2, SC 14F1 2, SC TO-I/A 2, 10-Q/A 1, 3/A 1, 8-A12B 1, 8-A12B/A 1, 8-A12G 1, 8-K12B 1, CERT 1, NT 10-Q 1, RW 1, S-3ASR 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 16:47 ET | [DEF 14A](/filings/0001104659-26-117868.md) | Proxy statement, period 2026-12-02 | 0001104659-26-117868 |
| 2026-10-14 | 17:11 ET | [8-K](/filings/0001104659-26-115874.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-115874 |
| 2026-10-05 | 08:00 ET | [8-K](/filings/0001104659-26-113503.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-113503 |
| 2026-09-24 | 16:24 ET | [10-K](/filings/0001104659-26-110420.md) | Annual report, period 2026-06-30 | 0001104659-26-110420 |
| 2026-09-24 | 16:16 ET | [8-K](/filings/0001104659-26-110412.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-110412 |
| 2026-06-02 | 07:05 ET | [8-K](/filings/0001104659-26-069206.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-069206 |
| 2026-05-12 | 16:20 ET | [10-Q](/filings/0001104659-26-059422.md) | Quarterly report, period 2026-03-31 | 0001104659-26-059422 |
| 2026-05-12 | 16:10 ET | [8-K](/filings/0001104659-26-059392.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059392 |
| 2026-05-04 | 16:30 ET | [8-K](/filings/0001104659-26-054943.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-054943 |
| 2026-03-24 | 07:30 ET | [8-K](/filings/0001104659-26-033592.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-033592 |
| 2026-02-12 | 16:36 ET | [10-Q](/filings/0001104659-26-014334.md) | Quarterly report, period 2025-12-31 | 0001104659-26-014334 |
| 2026-02-12 | 16:13 ET | [8-K](/filings/0001104659-26-014287.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-014287 |
| 2026-01-07 | 06:10 ET | [8-K](/filings/0001104659-26-001556.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-001556 |
| 2025-11-21 | 16:59 ET | [8-K](/filings/0001104659-25-115050.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-115050 |
| 2025-11-12 | 06:09 ET | [8-K](/filings/0001104659-25-109559.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-109559 |
| 2025-11-06 | 16:29 ET | [10-Q](/filings/0001104659-25-107781.md) | Quarterly report, period 2025-09-30 | 0001104659-25-107781 |
| 2025-11-06 | 16:16 ET | [8-K](/filings/0001104659-25-107743.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107743 |
| 2025-10-21 | 16:56 ET | [8-K](/filings/0001104659-25-101282.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors | 0001104659-25-101282 |
| 2025-10-07 | 16:16 ET | [DEF 14A](/filings/0001104659-25-097509.md) | Proxy statement, period 2025-11-19 | 0001104659-25-097509 |
| 2025-09-17 | 16:24 ET | [10-K](/filings/0001104659-25-090848.md) | Annual report, period 2025-06-30 | 0001104659-25-090848 |
| 2025-09-17 | 16:12 ET | [8-K](/filings/0001104659-25-090834.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-090834 |
| 2025-09-02 | 06:03 ET | [8-K](/filings/0001104659-25-085892.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-085892 |
| 2025-08-20 | 06:06 ET | [8-K](/filings/0001104659-25-080473.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-080473 |
| 2025-07-18 | 06:04 ET | [8-K](/filings/0001104659-25-068804.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-068804 |
| 2025-06-13 | 16:04 ET | [8-K/A](/filings/0001104659-25-059340.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-059340 |
| 2025-06-13 | 16:02 ET | [8-K](/filings/0001104659-25-059336.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-059336 |
| 2025-05-13 | 16:25 ET | [10-Q](/filings/0001558370-25-007582.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007582 |
| 2025-05-13 | 16:12 ET | [8-K](/filings/0001104659-25-047832.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-047832 |
| 2025-04-28 | 17:00 ET | [8-K](/filings/0001104659-25-040271.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-040271 |
| 2025-04-23 | 17:22 ET | [8-K](/filings/0001104659-25-038096.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-038096 |
| 2025-04-23 | 08:31 ET | [8-K](/filings/0001104659-25-037746.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-037746 |
| 2025-03-28 | 16:52 ET | [8-K](/filings/0001104659-25-029429.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-029429 |
| 2025-02-12 | 16:28 ET | [10-Q](/filings/0001558370-25-000867.md) | Quarterly report, period 2024-12-31 | 0001558370-25-000867 |
| 2025-02-12 | 16:13 ET | [8-K](/filings/0001104659-25-012173.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-012173 |
| 2025-02-04 | 17:11 ET | [8-K](/filings/0001104659-25-009180.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-009180 |
| 2025-01-14 | 16:30 ET | [8-K](/filings/0001104659-25-003460.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-003460 |
| 2025-01-07 | 16:05 ET | [8-K](/filings/0001104659-25-001666.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-001666 |
| 2024-12-10 | 16:43 ET | [8-K](/filings/0001104659-24-127228.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-127228 |
| 2024-11-07 | 16:47 ET | [10-Q](/filings/0001558370-24-014893.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014893 |
| 2024-11-07 | 16:38 ET | [8-K](/filings/0001104659-24-115351.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-115351 |
| 2024-10-21 | 16:41 ET | [DEF 14A](/filings/0001104659-24-110244.md) | Proxy statement, period 2024-12-05 | 0001104659-24-110244 |
| 2024-09-19 | 16:23 ET | [10-K](/filings/0001558370-24-012901.md) | Annual report, period 2024-06-30 | 0001558370-24-012901 |
| 2024-09-19 | 16:09 ET | [8-K](/filings/0001104659-24-101342.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-101342 |
| 2024-09-09 | 07:30 ET | [8-K](/filings/0001104659-24-097969.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-097969 |
| 2024-08-05 | 07:30 ET | [8-K](/filings/0001104659-24-085614.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-085614 |
| 2024-06-28 | 17:15 ET | [8-K](/filings/0001104659-24-076382.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-076382 |
| 2024-06-27 | 08:01 ET | [8-K](/filings/0001104659-24-075387.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-075387 |
| 2024-06-14 | 16:51 ET | [8-K](/filings/0001104659-24-071813.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-071813 |
| 2024-05-24 | 14:37 ET | [8-K](/filings/0001104659-24-065073.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-065073 |
| 2024-05-17 | 16:21 ET | [8-K](/filings/0001104659-24-063029.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-063029 |

Page 1 of 6. [Older](/companies/rzlt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:16 ET. No prices; not investment advice.